Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Caracemide

Related Products

Hot Products

Basic Information Post buying leads Suppliers
Name

Caracemide

EINECS N/A
CAS No. 81424-67-1 Density 1.259g/cm3
PSA 87.74000 LogP 0.22710
Solubility N/A Melting Point 122.25°C
Formula C6H11 N3 O4 Boiling Point 324.41°C (rough estimate)
Molecular Weight 189.171 Flash Point N/A
Transport Information N/A Appearance N/A
Safety Poison by ingestion, intravenous, and intraperitoneal routes. Human mutation data reported. When heated to decomposition it emits toxic fumes of NOx. Risk Codes N/A
Molecular Structure Molecular Structure of 81424-67-1 (Caracemide) Hazard Symbols N/A
Synonyms

Caracemide;N-Acetyl-N,O-di(methylcarbamoyl)hydroxylamine; NSC 253272

 

Caracemide Chemical Properties

IUPAC Name: [Acetyl(methylcarbamoyl)amino] N-methylcarbamate
Molecular Formula: C6H11N3O4
Molecular Weight: 189.20g/mol
Density: 1.259 g/cm3
Melting Point: 121–123.5°C 
Properties: crystals
Freely Rotating Bonds: 2
Polar Surface Area: 70.16 Å2
Index of Refraction: 1.479
Molar Refractivity: 42.59 cm3
Molar Volume: 150.1 cm3
Polarizability: 16.88× 10-24 cm3
Surface Tension: 44.2 dyne/cm 
The Cas Register Number of Caracemide is 81424-67-1.The chemical synonyms of Caracemide (CAS NO.81424-67-1) are Acetamide, N-((methylamino)carbonyl)-N-(((methylamino)carbonyl)oxy)- ; Acetamide, N-((methylamino)carbonyl)-N-((methylamino)carbonyl)oxy- ; Acetamide, N-[ (methylamino)carbonyl]-N-[[(methylamino)carbonyl]oxy]- ; Caracemida [Spanish] ; Caracemide (USAN)  .The molecular structure of Caracemide (CAS NO.81424-67-1) is .

Caracemide Uses

  Caracemide (CAS NO.81424-67-1) is used as pharmaceutical intermediate.

Caracemide Production


It is derived when Acetohydroxamic acid (I) reacts with two moles of methyl isocyanate (II).

Caracemide Toxicity Data With Reference

1.    

mmo-sat 5 µmol/plate

    MUREAV    Mutation Research. 172 (1986),199.
2.    

dni-hmn:leu 50 µmol/L

    NEOLA4    Neoplasma. 35 (1988),27.
3.    

orl-mus LD50:388 mg/kg

    NCISP*    National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program, Bethesda, MD 20205 JAN86 .
4.    

ipr-mus LD50:167 mg/kg

    NCISP*    National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program, Bethesda, MD 20205 JAN86 .
5.    

ivn-mus LD50:238 mg/kg

    NTIS**    National Technical Information Service. (Springfield, VA 22161) (Formerly U.S. Clearinghouse for Scientific and Technical Information) PB84-152032 .

Caracemide Safety Profile

Poison by ingestion, intravenous, and intraperitoneal routes. Human mutation data reported. When heated to decomposition it emits toxic fumes of NOx.

Caracemide Specification

Its extinguishing agent are water, carbon dioxide, foam and dry powder.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 81424-67-1